Paper41398264
Augmentation of antibacterial activity of ciprofloxacin by bisabololoxide A encapsulated in polymeric nanoparticles against uropathogenic Escherichia coli.
Bazgosha M and 10 others. BMC Biotechnol, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Augmentation of antibacterial activity of ciprofloxacin by bisabololoxide A encapsulated in polymeric nanoparticles against uropathogenic Escherichia coli. Papers, record 41398264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398264
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Augmentation of antibacterial activity of ciprofloxacin by bisabololoxide A encapsulated in polymeric nanoparticles against uropathogenic Escherichia coli.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ciprofloxacin | Major topic |
| Anti-Bacterial Agents | Major topic |
| Nanoparticles | Major topic |
| Uropathogenic Escherichia coli | Major topic |
| Biofilms | |
| Microbial Sensitivity Tests | |
| Polymers | |
| Drug Synergism | |
| Humans | |
| Polyethylene Glycols |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39558165 | PubChem 2025 update. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39558165 | PubMed |
| 2 | 26885364 | Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal. | Antimicrob Resist Infect Control | 2016 | https://conductscience.org/library/papers/26885364 | PubMed |
| 3 | 17196803 | A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. | Eur J Pharm Biopharm | 2007 | https://conductscience.org/library/papers/17196803 | PubMed |
| 4 | 18292097 | Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. | J Antimicrob Chemother | 2008 | https://conductscience.org/library/papers/18292097 | PubMed |
| 5 | 29201106 | Expression of TolC and Organic Solvent Tolerance of Escherichia Coli Ciprofloxacin Resistant Mutants. | Iran J Pharm Res | 2017 | https://conductscience.org/library/papers/29201106 | PubMed |
| 6 | 35454969 | Chamomile (Matricaria chamomilla L.): A Review of Ethnomedicinal Use, Phytochemistry and Pharmacological Uses. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35454969 | PubMed |
| 7 | 31219077 | Efflux pump inhibitors for bacterial pathogens: From bench to bedside. | Indian J Med Res | 2019 | https://conductscience.org/library/papers/31219077 | PubMed |
| 8 | 31635731 | Borneol-modified chitosan: Antimicrobial adhesion properties and application in skin flora protection. | Carbohydr Polym | 2020 | https://conductscience.org/library/papers/31635731 | PubMed |
| 9 | 31073992 | Silibinin encapsulation in polymersome: A promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of miR-125b/miR-182 in human breast cancer cells. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/31073992 | PubMed |
| 10 | 32038583 | The Antifungal Peptide MCh-AMP1 Derived From Matricaria chamomilla Inhibits Candida albicans Growth via Inducing ROS Generation and Altering Fungal Cell Membrane Permeability. | Front Microbiol | 2019 | https://conductscience.org/library/papers/32038583 | PubMed |
| 11 | 35164145 | Biotransformation of (-)-α-Bisabolol by Absidia coerulea. | Molecules | 2022 | https://conductscience.org/library/papers/35164145 | PubMed |
| 12 | 25500277 | Cinnamon bark oil and its components inhibit biofilm formation and toxin production. | Int J Food Microbiol | 2015 | https://conductscience.org/library/papers/25500277 | PubMed |
| 13 | 12534815 | Activity and mechanisms of action of selected biocidal agents on Gram-positive and -negative bacteria. | J Appl Microbiol | 2003 | https://conductscience.org/library/papers/12534815 | PubMed |
| 14 | 38566054 | Nanoformulated herbal compounds: enhanced antibacterial efficacy of camphor and thymol-loaded nanogels. | BMC Complement Med Ther | 2024 | https://conductscience.org/library/papers/38566054 | PubMed |
| 15 | 32592827 | Antibiofilm and anti-caries effects of an experimental mouth rinse containing Matricaria chamomilla L. extract under microcosm biofilm on enamel. | J Dent | 2020 | https://conductscience.org/library/papers/32592827 | PubMed |
| 16 | 39261709 | Valnemulin restores colistin sensitivity against multidrug-resistant gram-negative pathogens. | Commun Biol | 2024 | https://conductscience.org/library/papers/39261709 | PubMed |
| 17 | 24287850 | Escherichia coli in Europe: an overview. | Int J Environ Res Public Health | 2013 | https://conductscience.org/library/papers/24287850 | PubMed |
| 18 | 15264254 | UCSF Chimera--a visualization system for exploratory research and analysis. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15264254 | PubMed |
| 19 | 33132714 | Evaluation of antibacterial properties of Matricaria aurea on clinical isolates of periodontitis patients with special reference to red complex bacteria. | Saudi Pharm J | 2020 | https://conductscience.org/library/papers/33132714 | PubMed |
| 20 | 34172003 | Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study. | BMC Infect Dis | 2021 | https://conductscience.org/library/papers/34172003 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42461524 | Synthesis, antibacterial, and antibiofilm activities of an adenosine-benzoic acid conjugate against Streptococcus mutans and Escherichia coli: insights from molecular docking. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/42461524 | PubMed |
| 42234182 | Anti-biofilm and Efflux Pump Inhibitory Function of Fe3O4@SBA-3@Curcumin Nanoparticles on drug resistant isolates of Pseudomonas aeruginosa and Molecular Docking Analysis. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42234182 | PubMed |
| 42174494 | Anticancer effects of bisabolol oxide A-Loaded Micellar/Liposomal nanoparticles on DU-145 cells with deregulation of miR-34a and miR-181a: in silico and in vitro studies. | BMC Biotechnol | 2026 | https://conductscience.org/library/papers/42174494 | PubMed |
| 41877063 | Anticancer activity of an apigenin-functionalized silica-coated silver oxide nanocomposite against human gastric adenocarcinoma cells (AGS): in vitro and in silico analysis. | BMC Biotechnol | 2026 | https://conductscience.org/library/papers/41877063 | PubMed |
| 41652216 | Synergistic Antibacterial Activity of Quercetin-Functionalized Magnetic Nanoparticles Combined with Ciprofloxacin on Pathogenic Pseudomonas Aeruginosa Via Targeting Virulence, Efflux Pump, and Adhesion-Associated Genes and Molecular Docking Analysis. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/41652216 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41398264
GET https://conductscience.org/api/papers/v1/41398264/references?page=2